-
Impact of ‘Obamacare’ on Stakeholders – US Healthcare Policy.Obamacare on a roll in Florida despite sharp opposition
Imminent Surge in Prescription Drug Spending Prescription drug spending will…
Read more -
Who Cares for Made In India Brand?
The Food and Drug Administration (FDA) has disapproved exporting medicines…
Read more -
IPR Laws in Pharma : The Big Picture
In his recent State of the Union address, US President…
Read more -
FDA bans Indian firms from producing drugs for the U.S.
FDA bans Indian firms from producing drugs for the U.S.…
Read more -
pharmaTHMB.jpg GSK Pharma’s Rs.6,400 cr open offer begins Today!
The Britain-based GlaxoSmithKline Plc’s voluntary open offer to the shareholders…
Read more -
Indian Pharma sector marks 11.3% in January
The industry has overcome the hurdles in mid-2013 following the…
Read more -
Made in India medicines set alarm bells ringing in US
India, the second-largest exporter of over-the-counter and prescription drugs to…
Read more -
Indian bulk drug industry: Maintain quality conscience to face competition
Indian bulk drug industry: Maintain quality conscience to face competition…
Read more -
Indian Pharma Sector need stability with Growth
Fragmented Indian pharmaceutical market is facing high volatility and uncertainty. Increasing…
Read more -
India Protests : Commerce Minister Anand Sharma’s visit to Lahore
Putting the onus on India, Pakistan today said failure to…
Read more

